scholarly article | Q13442814 |
P356 | DOI | 10.1080/14728222.2018.1512587 |
P698 | PubMed publication ID | 30114962 |
P50 | author | Daniela Loessner | Q38544906 |
Peter Goettig | Q58229140 | ||
Judith Clements | Q17523861 | ||
P2093 | author name string | Julia Dorn | |
Viktor Magdolen | |||
Holger Bronger | |||
Sarah Preis | |||
Johanna Felber | |||
P2860 | cites work | Evaluating cell lines as tumour models by comparison of genomic profiles | Q37025950 |
P433 | issue | 9 | |
P921 | main subject | ovarian cancer | Q172341 |
P304 | page(s) | 745-763 | |
P577 | publication date | 2018-09-06 | |
P1433 | published in | Expert Opinion on Therapeutic Targets | Q5421214 |
P1476 | title | Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer | |
P478 | volume | 22 |
Q64097461 | Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients |
Q97539581 | High levels of KLK7 protein expression are related to a favorable prognosis in triple-negative breast cancer patients |
Q90620494 | Identification of potential biomarkers and pivotal biological pathways for prostate cancer using bioinformatics analysis methods |
Q64910062 | NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach. |